Affordable Access

Publisher Website

Effects of β-2 microglobulin anti-sense oligonucleotides on sensitivity of HER2/neu oncogene-expressing and nonexpressing target cells to lymphocyte-mediated lysis

Authors
Journal
Cellular Immunology
0008-8749
Publisher
Elsevier
Publication Date
Volume
141
Issue
1
Identifiers
DOI: 10.1016/0008-8749(92)90141-b

Abstract

Abstract The mechanism by which HER2/neu overexpressing tumor cells resist NK, LAK, and LDCC cytotoxic lymphocytes was investigated. Resistance was not explained by a delay in kinetics of lysis, concurrent resistance to TNF, or a diminished expression of the transferrin receptor. HLA-class I expression, however, was markedly elevated compared to HER2 nonexpressing targets suggesting a reason for resistance. To test the role of class I, we selectively decreased expression by incubation of targets with β-2 microglobulin anti-sense oligonucleotides. Anti-sense-treated HER2 + targets, displaying levels of class I comparable to HER2 − targets, were still markedly resistant to cytotoxic effectors. Down-regulation of class I expression in HER2 − carcinoma cells also had no effect on sensitivity to cytotoxicity but anti-sense treatment of Raji and U937 targets resulted in enhanced sensitivity to NK and LAK effectors but not to T cells mediating LDCC. These data indicate resistance to cytotoxicity in HER2-expressing targets cannot be solely explained by heightened expression of class I. The data also support the concept that class I expression regulates sensitivity to NK and LAK cells (but not LDCC effectors) in selected targets.

There are no comments yet on this publication. Be the first to share your thoughts.